Susan G. Komen®, the world’s leading breast cancer organization, today joined Sen. Mark Kelly (D-AZ) and actress and breast cancer survivor Olivia Munn in supporting the introduction of the Know Your Risk Act. This new, bipartisan legislation would build consensus around and promote the use of validated breast cancer risk assessment tools that can help people better understand their personal risk and make informed decisions about when to begin screening, what screening options are right for them, and steps they can take to reduce their breast cancer risk.

Ending deaths from breast cancer is Susan G. Komen’s mission and achieving that goal requires more than finding new treatments. It means identifying risk earlier and ensuring everyone has the information, resources and care they need to take action.

“Too many people are being diagnosed with breast cancer before anyone ever told them they were at risk, sometimes before they are even old enough for a first mammogram,” said Amber Guild, President & CEO of Susan G. Komen. “That is a failure we can fix. When people understand their risk early, they can begin screening sooner, advocate for the care they need, and catch this disease when it is most survivable. The Know Your Risk Act puts that power where it belongs, in people’s own hands, and it moves us toward the goal at the heart of our mission: finding breast cancer earlier, for everyone. We thank Senator Kelly for his leadership, and we will not rest until no one dies from breast cancer.”

In 2026 alone, an estimated 325,000 new cases of invasive breast cancer will be diagnosed in the U.S. More than 42,000 people are expected to die from the disease – many from marginalized communities. Breast cancer remains a leading cause of cancer death among Black women and Hispanic and Latina women. Incidence is rising fastest among Asian American and Pacific Islander women, while breast cancer death rates have remained unchanged over the past three decades among American Indian and Alaska Native women. For many, their diagnoses came too late.

We are also seeing breast cancer diagnoses rise faster among women under 50 than those over 50. In fact, breast cancer is the leading cause of cancer death among women ages 20–49. Yet many of our screening guidelines and approaches were not designed with younger women in mind underscoring the need for more personalized approaches that account for individual risk.

Today, breast cancer risk is not the same for everyone, and the way risk is assessed can be inconsistent or inaccurate. Health care providers use different assessment tools that consider a range of factors, including personal and family medical history, genetic factors, race and ethnicity and breast density. But there is no single, standardized approach to ensure these factors are consistently considered or that people have access to the tools they need to understand their individual risk.

“My mom and grandmother both had breast cancer, when I think about this disease, I think about them and my daughters and granddaughters. My friend Olivia Munn was able to catch her breast cancer early thanks to a risk assessment test. We know early detection saves lives. That’s why we’re teaming up on this bipartisan bill to make sure more women understand their risk, know what screening options are available to them, and have doctors who are using these tools to help them get the care they deserve,” said Sen. Kelly.

The Know Your Risk Act aims to change that. By establishing an interagency task force, the legislation will help advance strategies to improve access to and use of lifesaving breast cancer risk assessment tools and promote a more consistent approach that benefits everyone. The goal is to move beyond a one-size-fits-all approach to breast health care so people can better understand their personal risk, have more informed conversations with their health care providers and make screening decisions that are right for them.

“I know firsthand how powerful this tool can be because it led me to my breast cancer diagnosis, when other standard tools missed it, which ultimately helped save my life. Had it not been for that assessment, my breast cancer may not have been identified when it was. That experience is exactly why it’s important for other women to have access to the same opportunities. The goal of this legislation is to make an existing resource part of everyday care. Sometimes the most consequential changes don’t require reinventing the system, they require the people with the power to make a difference,” said Munn.

Susan G. Komen is the only organization that surrounds the entire disease — bringing research, patient care, education and advocacy together to end deaths from breast cancer. Komen has invested more than $1.1 billion in breast cancer research and contributed to the development of 31 of the last 32 FDA-approved breast cancer treatments and helped reduce the breast cancer death rate in the U.S. by 44% since 1989. It has also invested approximately $2.7 billion in patient support, community health and advocacy programs worldwide, working to break down the financial, social and systemic barriers that stand between people and lifesaving care.

The Know Your Risk Act is also championed by a bipartisan group of lawmakers, including Sen. Shelley Moore Capito (R-WV), Rep. Mariannette Miller-Meeks (R-IA-01), and Rep. Kim Schrier (D-WA-08).

About Susan G. Komen®

Susan G. Komen® is the world’s leading nonprofit breast cancer organization, working toward a future where no one dies from breast cancer. Komen has an unmatched, comprehensive 360-degree approach to fighting this disease across all fronts and supporting millions of people in the U.S. and in countries worldwide. We advocate for patients, drive research breakthroughs, improve access to high-quality care, offer direct patient support and empower people with trustworthy information. Founded by Nancy G. Brinker, who promised her sister, Susan G. Komen, that she would end the disease that claimed Suzy’s life, Komen remains committed to supporting those affected by breast cancer today, while tirelessly searching for tomorrow’s cures. Visit komen.org or call 1-877 GO KOMEN. Connect with us on social at www.komen.org/contact-us/follow-us/.

Media gallery

About The Author